Rchr
J-GLOBAL ID:202201001123564437   Update date: Feb. 01, 2024

Tanaka Ichidai

タナカ イチダイ | Tanaka Ichidai
Affiliation and department:
Job title: Assistant professor of hospital
Research field  (1): Respiratory medicine
Research keywords  (8): TTF-1陰性肺癌 ,  LKB1不活化肺癌 ,  分子生物学 ,  Mechanobiology ,  Metabolomics ,  Proteomics ,  Malignant Mesothelioma ,  Lung Cancer
Research theme for competitive and other funds  (8):
  • 2023 - 2026 ピリミジン塩基合成経路を標的としたLKB1不活化肺癌に対する新規治療法の開発
  • 2021 - 2024 ドライバー癌遺伝子誘導性の細胞老化を作用機序とする変異KRAS肺癌の創薬研究
  • 2021 - 2023 分泌タンパク質SMOC1を標的としたLKB1不活化肺癌における新規治療戦略の構築
  • 2020 - 2023 悪性中皮腫におけるオキシトシン受容体を標的とした新規治療法の開発
  • 2019 - 2021 部分的上皮間葉細胞転換(ハイブリッドEMT)の安定化因子を標的とする肺癌治療
Show all
Papers (37):
  • Nao Muraki, Mizuki Yamada, Hinako Doki, Riho Nakai, Kazuki Komeda, Daiki Goto, Nozomi Kawabe, Kohei Matsuoka, Miyoko Matsushima, Tsutomu Kawabe, et al. Resistance to mutant KRAS-induced senescence in a hTERT/Cdk4-immortalized normal human bronchial epithelial cell line. Experimental Cell Research. 2022. 414. 1. 113053-113053
  • Tanaka I, Morise M. Current immunotherapeutic strategies targeting the PD-1/PD-L1 axis in non-small cell lung cancer with oncogenic driver mutations. International Journal of Molecular Sciences. 2022. 23. 1
  • Ichidai Tanaka, Delphine Dayde, Mei Chee Tai, Haruki Mori, Luisa M Solis, Satyendra C Tripathi, Johannes F Fahrmann, Nese Unver, Gargy Parhy, Rekha Jain, et al. SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. Journal of the National Cancer Institute. 2021. 114. 2. 290-301
  • Ichidai Tanaka, Taiki Furukawa, Masahiro Morise. The current issues and future perspective of artificial intelligence for developing new treatment strategy in non-small cell lung cancer: harmonization of molecular cancer biology and artificial intelligence. Cancer Cell International. 2021. 21. 1. 454
  • Reiko Matsuzawa, Masahiro Morise, Ichidai Tanaka, Shunsaku Hayai, Yutaro Tamiya, Junji Koyama, Tetsunari Hase, Keiko Wakahara, Deoksu Kim, Yoshie Shimoyama, et al. Amelanotic Malignant Melanoma with a BRAF V600E Mutation Mimicking Primary Lung Cancer. Internal medicine (Tokyo, Japan). 2021. 61. 5. 703-708
more...
Books (2):
  • 大気・室内環境関連疾患 予防と対策の手引き 2019
    一般社団法人 日本呼吸器学会 2019
  • Interstitial pneumonia and nodular regenerative hyperplasia of the liver as initial manifestations of polyarteritis nodosa
    Internal Medicine 2012
Lectures and oral presentations  (18):
  • Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
    (第25回アジア太平洋呼吸器学会学術集会 2021)
  • SRGN triggered aggressive and immunosuppressive phenotype in TTF-1 negative lung adenocarcinomas
    (2020)
  • Potential benefits of bevacizumab plus platinum-based chemotherapy in advanced non-small-cell lung cancer patients with EGFR mutation
    (2020)
  • eIF2b is a Potential Therapeutic Target for Nonsmall Cell Lung Cancer
  • A LIM protein ajuba suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade.
    (AACR 104th Annual Meeting 2013)
more...
Awards (1):
  • 2013/07 - 名古屋大学 名大内科学研究奨励賞
Association Membership(s) (8):
アジア太平洋呼吸器学会学術集会 ,  日本内科学会 ,  日本呼吸器学会 ,  日本呼吸器内視鏡学会 ,  日本癌学会 ,  日本臨床腫瘍学会 ,  日本肺癌学会 ,  AACR
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page